Ketamine beyond anesthesia: Antidepressant effects and abuse potential.
Trujillo KA, Iñiguez SD.
Behav Brain Res. 2020 Sep 15;394:112841. doi: 10.1016/j.bbr.2020.112841. Epub 2020 Jul 31.
Ketamine abuse potential and use disorder.
Liu Y, Lin D, Wu B, Zhou W.
Brain Res Bull. 2016 Sep;126(Pt 1):68-73. doi: 10.1016/j.brainresbull.2016.05.016. Epub 2016 May 31.
Antidepressant Withdrawal and Rebound Phenomena.
Henssler J, Heinz A, Brandt L, Bschor T.
Dtsch Arztebl Int. 2019 May 17;116(20):355-361. doi: 10.3238/arztebl.2019.0355.
Safety of Psychotropic Medications During Pregnancy.
Raffi ER, Nonacs R, Cohen LS.
Clin Perinatol. 2019 Jun;46(2):215-234. doi: 10.1016/j.clp.2019.02.004. Epub 2019 Mar 28.
Incidence of antidepressant discontinuation symptoms: a systematic review and meta-analysis.
Henssler J, Schmidt Y, Schmidt U, Schwarzer G, Bschor T, Baethge C.
Lancet Psychiatry. 2024 Jul;11(7):526-535. doi: 10.1016/S2215-0366(24)00133-0. Epub 2024 Jun 5.
Antidepressant discontinuation syndrome.
Warner CH, Bobo W, Warner C, Reid S, Rachal J.
Am Fam Physician. 2006 Aug 1;74(3):449-56.
Antidepressant discontinuation reactions.
Haddad P, Lejoyeux M, Young A.
BMJ. 1998 Apr 11;316(7138):1105-6. doi: 10.1136/bmj.316.7138.1105.
Antidepressant discontinuation syndromes.
Haddad PM.
Drug Saf. 2001;24(3):183-97. doi: 10.2165/00002018-200124030-00003.
Borderline Personality Disorder: Clinical Guidelines for Treatment.
Stone MH.
Psychodyn Psychiatry. 2022 Spring;50(1):45-63. doi: 10.1521/pdps.2022.50.1.45.
Comorbid alcohol and substance abuse dependence in depression: impact on the outcome of antidepressant treatment.
Ostacher MJ.
Psychiatr Clin North Am. 2007 Mar;30(1):69-76. doi: 10.1016/j.psc.2006.12.009.
